Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Issued: 2013-2025

Historic Shares Issued for Amphastar Pharmaceuticals (AMPH) over the last 3 years, with Sep 2025 value amounting to $379,000.

  • Amphastar Pharmaceuticals' Shares Issued was N/A to $379,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year change of. This contributed to the annual value of $11.0 million for FY2023, which is 29.91% down from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Shares Issued is $379,000, which was down 89.35% from $3.6 million recorded in Q4 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Shares Issued peaked at $5.7 million during Q4 2021, and registered a low of $379,000 during Q3 2025.
  • Its 2-year average for Shares Issued is $2.0 million, with a median of $2.1 million in 2023.
  • Its Shares Issued has fluctuated over the past 5 years, first surged by 205.50% in 2021, then plummeted by 64.00% in 2022.
  • Amphastar Pharmaceuticals' Shares Issued (Quarterly) stood at $5.7 million in 2021, then plummeted by 64.00% to $2.0 million in 2022, then spiked by 74.68% to $3.6 million in 2023, then reached $379,000 in 2025.
  • Its Shares Issued stands at $379,000 for Q3 2025, versus $3.6 million for Q4 2023 and $2.1 million for Q3 2023.